Public health officials say that person with measles visited Boston
The Boston Public Health Commission (BPHC) and the Massachusetts Department of Public Health (DPH) is informing the public that a person with measles has visited Boston.
Officials say that the individual was in Boston between the dates of June 7 and June 8. In that time frame, the individual visited several places while infected, including:
Westin Boston Seaport District Hotel (including restaurants in the hotel) between 5:30 pm on Saturday, June 7, and 1:30 pm on Sunday, June 8
The Museum of Fine Arts, Boston, between 1:00 pm and 6:30 pm on Sunday, June 8
Logan Airport Terminal C between 5:00 pm and 11:15 pm on Sunday, June 8
The person then flew on JetBlue Flight 639 to Miami, which departed at 9:12 pm.
Measles is a highly contagious virus that gives flu-like symptoms, including cough, high fever, runny nose, and red, watery eyes, followed by a red, blotchy rash that spreads from the face to the rest of the body.
Typically when a person who has contracted the virus can spread the disease through breathing, sneezing, and coughing.
'This case of measles highlights the importance of obtaining the MMR vaccine to protect ourselves and our community. The MMR vaccine is highly effective at preventing measles infection and also protects against mumps and rubella,' said Dr. Bisola Ojikutu, Commissioner of Public Health for the City of Boston. 'Children should receive the vaccine at 12-15 months of age and again before kindergarten to ensure strong immunity. Children who are at least 6 months old who are traveling internationally should receive an early dose of vaccine before traveling. It is never too late for children or adults to get the measles vaccine and for the vaccine to be effective, even if they are past the age recommended by doctors.'
The DPH is working to help identify those who may have been exposed to the virus. Those who were exposed should contact their health care provider immediately and monitor for symptoms for at least 21 days, and avoid public places.
According to the DPH, the measles vaccination is 93%-97% effective in preventing measles and protecting against severe disease. In Suffolk County, 94% of children have been fully vaccinated against measles, according to DPH data. Vaccinated individuals are at low risk of contracting measles.
Health officials urge people who do not know their immunization status to get vaccinated with at least one dose of the Measles, Mumps, and Rubella (MMR) vaccine.
For more information on measles, visit Boston.gov/measles
This is a developing story. Check back for updates as more information becomes available.
Download the FREE Boston 25 News app for breaking news alerts.
Follow Boston 25 News on Facebook and Twitter. | Watch Boston 25 News NOW
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
West Nile Virus found in mosquitoes in Lubbock County, warns city. Here's what to know
The City of Lubbock is warning Lubbock County residents that West Nile Virus has been detected in mosquitoes in the county. According to the city, the Biological Threat Research Lab at Texas Tech University has notified the Lubbock Health Department that mosquitoes carrying West Nile Virus are active in Lubbock County. Others are reading: What's coming in Lubbock County's proposed budget? Here's what's being discussed In response, the vector control teams will increase spraying within the community, with the city strongly urging the public to take precautions to reduce mosquito bites and help prevent the spread of the virus. The city is also asking residents to help prevent the spread of the virus by reporting biting adult mosquitoes or reporting a suspected mosquito breeding site. According to the health department, West Nile is a disease of birds that humans are exposed to after a mosquito has fed on an infected bird. Humans can only contract it from mosquitoes and cannot pass it to other humans. For more information about West Nile Virus, visit the CDC website: According to the health department, here are the common symptoms: Headache. Fever. Muscle and joint aches. Nausea. Fatigue. Symptoms involving the central nervous system can also develop, which include neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, and paralysis. According to the health department, most infected people show no symptoms, with most recovering on their own. Currently, there are no medications or vaccines to prevent or treat infection. People over 50 years old and those with other health issues are at a higher risk of becoming seriously ill. If people have symptoms and suspect West Nile Virus infection, they should contact their healthcare provider. Individuals can take the following steps to prevent infection this holiday week and throughout summer: Wearing an EPA-registered insect repellant Covering up with long-sleeved shirts and long pants Keeping mosquitoes out of living areas by using air conditioning or intact window screens Limiting outdoor activities during peak mosquito times Dumping standing water around your home As of June 18, there have been no reported human West Nile infection cases or deaths in Lubbock in 2025. Mateo Rosiles is the Government & Public Policy reporter for the Lubbock Avalanche-Journal. Got a news tip for him? Email him: mrosiles@ This article originally appeared on Lubbock Avalanche-Journal: West Nile Virus found in mosquitoes around Lubbock, city urges caution
Yahoo
38 minutes ago
- Yahoo
Sana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment Results
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the 10 best healthcare penny stocks to buy according to analysts. The company's stock surged 12.1% on June 23 after it announced positive six-month follow-up results from an investigator-sponsored, first-in-human study of its type 1 diabetes treatment. A laboratory cultivating cells for the development of gene and cell therapies. The therapy in focus is UP421, which consists of cadaver-sourced pancreatic islet cells that have been genetically modified using Sana's hypoimmune (HIP) technology to evade immune detection. A significant finding is that the transplanted cells were safe, well-tolerated, survived, and continued to produce insulin in the patient without the need for immunosuppressive medicines. The study identified no safety issues, and the HIP-modified islet cells successfully evaded immune responses (both allogeneic and autoimmune). Per-Ola Carlsson, MD, Study Principal Investigator, Senior Physician, and Professor at the Clinic for Uppsala University Hospital, stated that the consistent results at four-week, 12-week, and now six-month follow-ups continue to suggest that a functional cure for type 1 diabetes without immunosuppression is possible. Sana Biotechnology, Inc. (NASDAQ:SANA) is a biotechnology company. It develops engineered cell therapies to treat serious diseases, aiming to repair or replace damaged cells. Its platforms include hypoimmune cells, gene delivery, and in vivo cell engineering. Sana's pipeline targets conditions like cancer, type 1 diabetes, and genetic disorders. While we acknowledge the potential of SANA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: Goldman Sachs Energy Stocks: 10 Stocks to Buy and 10 Best AI Stocks to Buy According to Billionaire David Tepper. Disclosure: None.
Fox News
42 minutes ago
- Fox News
Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells
A potentially deadly fungus known as "pharaoh's curse fungus" could offer an unexpected path to fighting cancer, recent research shows. Scientists from the University of Pennsylvania modified molecules from the fungus — which is officially called Aspergillus flavus — to create a new compound and enhance its cancer-killing properties. "Fungi gave us penicillin," said Dr. Xue (Sherry) Gao, an associate professor at UPenn and leader of the study, in a press release. "These results show that many more medicines derived from natural products remain to be found." The findings were published in the journal Nature Chemical Biology. Aspergillus flavus is found in decaying leaves and compost, as well as on trees, plants and some crops, according to Mayo Clinic. While the fungus doesn't endanger most healthy people, it can cause respiratory issues for those who have weakened immune systems or are taking certain medications. Some of the more severe complications of the fungus can include bleeding in the lungs and life-threatening infections in the brain, heart and kidneys, Mayo Clinic stated. After archaeologists opened King Tut's tomb in the 1920s, multiple members of the excavation team died suddenly, fueling rumors of a "curse" upon those who dared interfere with the pharaoh's rest, according to the UPenn press release. Decades later, doctors hypothesized that fungal spores, which had been dormant for thousands of years, could have infected the team. In the 1970s, it happened again, the university stated. A dozen scientists entered another tomb, this time in Poland — and 10 died within a few weeks. Later investigations were said to reveal the presence of Aspergillus flavus in the tomb. Now, the same fungus linked to King Tut's tomb could have the capability to fight leukemia in a new form of cancer therapy. "There are a variety of compounds able to be produced by fungus," Gao told Fox News Digital. These compounds can be toxic to different cells, she noted, depending on the "biological management we are able to mitigate." The study aimed to find a specific kind of compound — ribosomally synthesized and post-translationally modified peptides, or "RiPPs" — within Aspergillus flavus, which was previously shown to be a good source. When this compound is able to enter cancer cells, Gao said, it may be able to stop their growth. "Cancer cells divide uncontrollably," Gao said in the release. "These compounds block the formation of microtubules, which are essential for cell division." When mixed with human cancer cells, two variants of the molecules within these RiPPS were found to have potent effects against leukemia cells, the researchers found. Another variant performed as well as two FDA-approved drugs that have been used for decades to treat leukemia (cytarabine and daunorubicin). Tiffany Troso-Sandoval, M.D., a medical oncologist and cancer care consultant based in New York, cautioned that this study, which was performed on cell cultures, is still in the very early stages. "It's still very far away from being applicable to use in humans with leukemia," Troso-Sandoval, who was not involved in the study, told Fox News Digital. Speaking about RiPPs, the doctor told Fox News Digital, "What they're referring to [in the study] is basically a rare type of bioactive molecule that they have isolated from this fungus." There are multiple subtypes of leukemia, Troso-Sandoval pointed out, including acute and chronic forms. "One treatment might not work on [another] type of leukemia," she noted. Further testing is needed to determine which subtypes may contain the active molecule. The compound explored in the study had little to no effect on breast, liver or lung cancer cells, the researchers noted. This suggests that its disruptive effects only work on certain types of cells, which will be an important consideration when developing medications. Looking ahead, the researchers plan to test the fungus' potential in animal models and, ultimately, human trials. Gao told Fox News Digital she is "excited about what nature can create and how it can benefit our society." For more Health articles, visit The study received support from the National Institutes of Health, the University of Pennsylvania, the Welch Foundation, the Houston Area Molecular Biophysics Program, the Cancer Prevention and Research Institute of Texas and the National Science Foundation.
